2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 139 filers reported holding 2SEVENTY BIO INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,055,754 | -42.1% | 779,529 | +49.5% | 0.02% | -40.0% |
Q2 2023 | $5,275,192 | +345.2% | 521,264 | +348.7% | 0.03% | +328.6% |
Q1 2023 | $1,185,036 | +9.9% | 116,180 | +0.9% | 0.01% | 0.0% |
Q4 2022 | $1,078,628 | -28.1% | 115,115 | +11.7% | 0.01% | -41.7% |
Q3 2022 | $1,500,000 | – | 103,068 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Newtyn Management, LLC | 1,587,805 | $27,088,000 | 6.49% |
CHI Advisors LLC | 819,672 | $13,984,000 | 5.95% |
Madison Avenue Partners, LP | 896,972 | $15,302,342,000 | 2.86% |
Bain Capital Life Sciences Investors, LLC | 1,408,901 | $24,036,000 | 2.33% |
EcoR1 Capital, LLC | 3,495,943 | $59,641,000 | 1.87% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $5,118,000 | 1.02% |
CVI Holdings, LLC | 819,672 | $13,984,000 | 0.92% |
ARMISTICE CAPITAL, LLC | 2,000,000 | $34,120,000 | 0.66% |
Altium Capital Management LP | 115,000 | $1,962,000 | 0.66% |
Casdin Capital, LLC | 614,754 | $10,488,000 | 0.47% |